RxDoctor Payments Data

Kyle Planchard, MD

Sports Medicine · Shreveport, LANPI 1427549120

Payments from drug & device makers

What this record shows

This record is dominated by grants: $22,917 of the $29,403 with a category attached, or 77.9%. Arthrex accounts for 68.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $23,191 and has fallen 97.3% since, to $619 in 2025.

$29,403in general payments, 2019–2025

Across 62 payments — averaging $474.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$20K
  • Smith+Nephew$6K
  • Stryker$2K
  • Prime Surgical, LLC$488
  • Johnson & Johnson$378
  • Zimmer Biomet$218
  • plus $477 from 5 others

What the payments were for

  • Grants$22,91778%
  • Travel & lodging$3861%
  • Food & beverage$3,18411%
  • Education$2,91710%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex2$20,166
Smith+Nephew5$6,058
Stryker37$1,618
Prime Surgical, LLC1$488
Johnson & Johnson4$378
Zimmer Biomet2$218
Bioventus LLC3$183
Midsouth Orthopedics Inc.1$131
Medical Device Business Services, Inc.4$117
Vertex2$30
Solventum Corporation1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,403 in reported general payments places this provider in the 85th percentile of 82 sports medicine providers in Louisiana.

See all sports medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$35,391
Medicare patients
109
Services billed
386

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl12$82
Meloxicam12$47

Paid to pharmacies, not to this prescriber.

Other sports medicine in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →